Genetic Aortic Disorders Association Canada

What Genetic Aortic Disorders Association Canada does

Genetic Aortic Disorders Association Canada (GADA Canada) is a Canadian registered charitable nonprofit founded in 1986 (originally as the Canadian Marfan Association) and renamed in 2015 to reflect its broadened mandate across heritable thoracic aortic disorders. Headquartered in Mississauga, Ontario, the organization is the only entity in Canada dedicated to genetic aortic disorders and operates with a lean staff of 1-10 employees. Its mission centers on patient education, peer support, awareness, advocacy, and funding of scientific research for conditions including Marfan syndrome, Loeys-Dietz syndrome, and 14+ other identified genetic mutations (FBN1, ACTA2, SMAD3, TGFB2/3, MYLK, PRKG1, MYH11, MAT2A, MFAP5, SLC2A10).

GADA Canada's core 'products' are programmatic rather than commercial: an annual research grant program running since 1999; co-founding and continued funding of the Montalcino Aortic Consortium (MAC), an international patient registry and research collaboration spanning the USA, Canada, Europe, Australia, and Japan; the annual Heritable Aortic Disorders Symposium co-hosted with Peter Munk Cardiac Centre; a webinar series and email newsletter; a Canada-wide clinic directory; the THINK AORTA Canada public awareness campaign (launched April 2024) targeting Emergency Department detection of aortic dissection; and parliamentary advocacy culminating in formal House of Commons recognition on November 3, 2025. There is no proprietary technology stack — the organization explicitly notes its core technology is not applicable as it is a patient advocacy and research funding body.

The business model is that of a donor- and grant-funded nonprofit. Revenue streams comprise individual donations, memorial giving, fundraising events (e.g., the Jason 'Ruffy' Keith Memorial Pool Tournament), and significant foundation grants — most notably from the Temerty Family Foundation, which provided the largest grant in the organization's history in 2021 to support a five-year strategic plan plus $261,700 (CAD) earmarked for the MAC registry. Customer segments are non-transactional: patients and families affected by genetic aortic disorders (primary), families/caregivers, and healthcare professionals/researchers. Distribution occurs through gadacanada.ca (English and French), social channels, webinars, in-person conferences rotating across Canadian cities (Toronto, Montreal, Halifax), and partnerships with the American Association of Thoracic Surgeons and John Ritter Research Foundation.

Name

Genetic Aortic Disorders Association Canada

Legal name

The Genetic Aortic Disorders Association (GADA) Canada

Website

https://gadacanada.ca

Company type

Private

Founded year

1986

Operating status

Operating

Headcount range

1–10 employees

Short description

GADA Canada is a Mississauga-based registered charity and the only Canadian organization dedicated to genetic aortic disorders, providing patient education, peer support, research grants, and awareness across 14+ heritable conditions since 1986.

Ownership category

akta.pro rank

Product category

Patient Advocacy and Health Support Services

NAICS

Voluntary Health Organizations (813212), Grantmaking and Giving Services (81321)

SIC

Services-Membership Organizations (8600)

akta.pro primary industry

Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS) (BPAGACAA)

akta.pro secondary industry

Global Health Research, Evidence & Technical Assistance Organizations (HLAJAKAN)

Keywords

• Patient advocacy services
• Genetic disorder education
• Medical research grants
• Rare disease support
• Community health resources

Headquarters

HQ city

Mississauga

HQ country

Canada

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure, Others

Revenue model

1. Donations and Fundraising: GADA Canada raises funds through individual donations, memorial donations in honor of deceased loved ones, and fundraising events such as the annual Jason 'Ruffy' Keith Memorial Pool Tournament. The organization also receives matching gift challenges from supporters.
2. Research Grants: The organization receives significant grants from foundations including the Temerty Family Foundation to fund research grants, organizational growth, and the Montalcino Aortic Consortium registry. In 2021, GADA received its largest grant from the Temerty Foundation for a five-year strategic plan.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels8 records

Core offering

GADA Canada is a nonprofit patient advocacy organization that provides education, support resources, and advocacy for individuals and families affected by genetic aortic disorders (including Marfan syndrome, Loeys-Dietz syndrome, and related HTAD conditions). It funds scientific research through grants and the Montalcino Aortic Consortium international patient registry, hosts national conferences, webinars, and awareness campaigns, and maintains a directory of specialized clinics across Canada.

Product overview

GADA Canada is a patient advocacy organization offering a comprehensive suite of programs and services for individuals affected by genetic aortic disorders. The core offerings include patient education and support programs with online resources and community groups; an annual research grant program funding scientific research since 1999; and co-founding the Montalcino Aortic Consortium international patient registry for heritable thoracic aortic disease. Additional services include national conferences and symposia, webinar series on disease management, email newsletters, a clinic directory for Canada-wide care access, and the THINK AORTA Canada awareness campaign. The organization serves as the primary Canadian resource for Marfan syndrome and related genetic aortic conditions.

Differentiator

Problem solved

Functional benefit

Products and services

• Patient Education and Support Programs Educational resources, peer support groups, and informational materials for patients and families affected by genetic aortic disorders including Marfan syndrome, Loeys-Dietz syndrome, and other heritable thoracic aortic diseases.
• Research Grant Program Annual research grant awards funding scientific research into genetic aortic disorders, including projects on molecular mechanisms, clinical biomarkers, and therapeutic interventions for conditions such as Marfan syndrome. Grants of approximately $50,000 per recipient are funded primarily by the Temerty Family Foundation.
• Montalcino Aortic Consortium (MAC) Registry International research collaboration co-founded by GADA Canada in 2013, maintaining a global patient registry for heritable thoracic aortic disorders to define optimal gene-based clinical management. GADA provides $261,700 for registry expansion.
• National Conferences and Symposia Annual heritable aortic disorders conferences bringing together medical specialists, researchers, patients, and families, including biennial national GADA conferences and the Heritable Aortic Disorders (HAD) Symposiums.
• Webinar Series Online educational webinars covering topics such as healthy living with aortic disease, transitional care for aortic disorders, and new clinical guidelines for patients and families.
• Clinics Across Canada Directory Resource listing specialized clinics across Canada that provide care for patients with genetic aortic disorders, helping patients find appropriate medical care.
• THINK AORTA Canada Campaign Public awareness campaign launched in 2024 to improve detection, diagnosis and treatment of aortic dissection in Canada, developed in partnership with the international THINK AORTA movement.

Quantifiable outcome

• Parliamentary recognition of aortic disorders awareness on November 3, 2025
• +1 more outcomes

Named customers1 record

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Five partnerships are on record, tiered core and minor.

• THINK AORTAcoreStrategic or Co-development Partner · 27 April 2024GADA Canada partners with the international THINK AORTA campaign to launch THINK AORTA Canada. This patient-led movement aims to improve detection, diagnosis, and treatment of aortic dissection in Canadian Emergency Departments. The campaign was launched at the American Association of Thoracic Surgeons Annual Meeting in Toronto, with GADA Canada's Acting President Lindsey Rusche serving as Patient Lead.
• John Ritter Research FoundationminorStrategic or Co-development Partner · 1 January 2020Partnership during Aortic Dissection Awareness Week (September 19-26, 2020) to host a virtual conference featuring medical professional talks, peer support sessions, and Frequently Asked Aortic Questions video content.
• Peter Munk Cardiac Centre, University Health NetworkcoreStrategic or Co-development Partner · 1 January 2016Co-host of annual Heritable Aortic Disorders Symposiums. Dr. Maral Ouzounian, Chief of Cardiovascular Surgery at UHN, serves as Chair of GADA's Professional Advisory Board and leads the Toronto Aortopathy Clinic. GADA and PMCC collaborate on patient education and research initiatives.
• American College of Cardiology/American Heart AssociationminorStrategic or Co-development Partner · 1 January 2016GADA acknowledges contributions of MAC members Dr. Dianna Milewicz and Dr. Alan Braverman who participated in the joint guidelines writing committee for new aortic disease diagnosis and management guidelines.
• Montalcino Aortic Consortium (MAC)coreStrategic or Co-development Partner · 1 January 2013GADA Canada co-founded and continues to fund the Montalcino Aortic Consortium, an international research collaboration of physician-scientists from aortic centers worldwide. MAC maintains a global patient registry for heritable thoracic aortic disorders spanning USA, Canada, Europe, Australia, and Japan. GADA provides $261,700 for registry expansion.

Scale indicators5 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• The Marfan Foundation: The leading US-based nonprofit dedicated to Marfan syndrome and related connective tissue/aortic disorders. Most directly comparable peer — same disease focus (Marfan and related HTAD), same advocacy-plus-research-funding model, same target audience of patients, families, and clinicians.
• Loeys-Dietz Syndrome Foundation: US-based patient advocacy and research funding organization focused specifically on Loeys-Dietz syndrome (one of the genetic aortic disorders GADA also covers). Directly comparable in mission, scope, and stakeholder community.
• John Ritter Foundation for Aortic Health: US nonprofit focused on thoracic aortic aneurysm and dissection awareness, education, and research — the same disease area as GADA. Directly comparable as a small disease-specific aortic health advocacy organization.
• The Ehlers-Danlos Society: International nonprofit for Ehlers-Danlos syndromes and related connective tissue disorders, several of which overlap with genetic aortic disorders (e.g., vascular EDS). Comparable in patient advocacy, education, and research funding for a rare connective tissue disease community.

Broad incumbents

• Genetic Alliance: Large US-based umbrella advocacy organization serving hundreds of genetic disease communities. GADA is comparable as a genetic-disease-focused nonprofit operating in Genetic Alliance's broader ecosystem of condition-specific patient groups.
• National Organization for Rare Disorders (NORD): US umbrella organization representing the rare disease community including genetic aortic disorders. GADA operates as a disease-specific affiliate within the broader rare-disease advocacy ecosystem that NORD anchors.
• Canadian Organization for Rare Disorders (CORD): Canada's national umbrella for rare disease advocacy. GADA is a disease-specific Canadian advocacy nonprofit that operates within CORD's broader Canadian rare-disease policy ecosystem.
• Heart & Stroke Foundation of Canada: Canada's largest cardiovascular health charity. GADA's aortic disease work overlaps with Heart & Stroke's broader cardiovascular mandate, and both compete for Canadian donor dollars in cardiovascular health.

Emerging players

• Aortic Dissection Awareness: Smaller US-focused patient-led initiative raising awareness about aortic dissection. Comparable as a community-driven, awareness-focused organization addressing the same clinical event (aortic dissection) that GADA's THINK AORTA Canada campaign also targets.

Others

• Canadian Medical Association: National professional body representing Canadian physicians. GADA's professional advisory board work, guideline dissemination (ACC/AHA aortic guidelines), and clinician-education conferences align GADA with CMA's physician membership and CME ecosystem.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/@gadacanada
• Facebookfacebook.com/Aorticdisorders
• LinkedInlinkedin.com/company/genetic-aortic-disorders-association-gada-canada

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Genetic Aortic Disorders Association Canada